Dabur's Silvassa plant flagged by US FDA under Import Alert 66-40 over data integrity gaps
US FDA placed select private-label exports from Dabur's Silvassa facility under Import Alert 66-40, citing data integrity concerns. Dabur calls the financial hit immaterial, says domestic products and plant operations are unaffected, and has arranged alternative sourcing for the US market. Shares trade at ₹423, down 1.15% intraday and 15% YTD 2026.
US FDA placed certain private-label products from Dabur's Silvassa facility under Import Alert 66-40 citing data integrity gaps. Dabur says impact is immaterial, domestic products unaffected, plant operational, and alternative sourcing arranged for US market.